Click for best price
Pulmonary Drug Delivery Devices & Systems Market Size, Share 2024
| Market size in 2023 |
US$ 2873 million
|
Forecast Market size by 2030 |
US$ 3785.9 million
|
| Growth Rate |
CAGR of 4.1% |
Number of Pages |
95 Pages |
The global Pulmonary Drug Delivery Devices & Systems market was valued at US$ 2873 million in 2023 and is projected to reach US$ 3785.9 million by 2030, at a CAGR of 4.1% during the forecast period.
This research report provides a comprehensive analysis of the Pulmonary Drug Delivery Devices & Systems market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Pulmonary Drug Delivery Devices & Systems market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Pulmonary Drug Delivery Devices & Systems, challenges faced by the industry, and potential opportunities for market players.
The global Pulmonary Drug Delivery Devices & Systems market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Pulmonary Drug Delivery Devices & Systems market presents opportunities for various stakeholders, including Hospitals and Clinics, Homecare. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Pulmonary Drug Delivery Devices & Systems market. Additionally, the growing consumer demand present avenues for market expansion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Pulmonary Drug Delivery Devices & Systems market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Pulmonary Drug Delivery Devices & Systems market.
Market Overview: The report provides a comprehensive overview of the Pulmonary Drug Delivery Devices & Systems market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Metered Dose Inhalers, Dry Powder Inhalers), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Pulmonary Drug Delivery Devices & Systems market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Pulmonary Drug Delivery Devices & Systems market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Pulmonary Drug Delivery Devices & Systems market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Pulmonary Drug Delivery Devices & Systems market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Pulmonary Drug Delivery Devices & Systems market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Pulmonary Drug Delivery Devices & Systems market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Pulmonary Drug Delivery Devices & Systems, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Pulmonary Drug Delivery Devices & Systems market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Pulmonary Drug Delivery Devices & Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Accessories
Market segment by Application
- Hospitals and Clinics
- Homecare
Global Pulmonary Drug Delivery Devices & Systems Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Hovione
- 3M Health Care
- Bespak
- BeyonDevices
- GlaxoSmithKline
- H&T Presspart
- PARI Respiratory Equipment
- Philips Respironics
- SHL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pulmonary Drug Delivery Devices & Systems, market overview.
Chapter 2: Global Pulmonary Drug Delivery Devices & Systems market size in revenue and volume.
Chapter 3: Detailed analysis of Pulmonary Drug Delivery Devices & Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pulmonary Drug Delivery Devices & Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pulmonary Drug Delivery Devices & Systems capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Pulmonary Drug Delivery Devices & Systems Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 2873 million
|
| Forecast Market size by 2030 |
US$ 3785.9 million
|
| Growth Rate |
CAGR of 4.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
95 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pulmonary Drug Delivery Devices & Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Drug Delivery Devices & Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Drug Delivery Devices & Systems Overall Market Size
2.1 Global Pulmonary Drug Delivery Devices & Systems Market Size: 2023 VS 2030
2.2 Global Pulmonary Drug Delivery Devices & Systems Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Pulmonary Drug Delivery Devices & Systems Sales: 2019-2030
3 Company Landscape
3.1 Top Pulmonary Drug Delivery Devices & Systems Players in Global Market
3.2 Top Global Pulmonary Drug Delivery Devices & Systems Companies Ranked by Revenue
3.3 Global Pulmonary Drug Delivery Devices & Systems Revenue by Companies
3.4 Global Pulmonary Drug Delivery Devices & Systems Sales by Companies
3.5 Global Pulmonary Drug Delivery Devices & Systems Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Pulmonary Drug Delivery Devices & Systems Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Pulmonary Drug Delivery Devices & Systems Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Drug Delivery Devices & Systems Players in Global Market
3.8.1 List of Global Tier 1 Pulmonary Drug Delivery Devices & Systems Companies
3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Devices & Systems Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary Drug Delivery Devices & Systems Market Size Markets, 2023 & 2030
4.1.2 Metered Dose Inhalers
4.1.3 Dry Powder Inhalers
4.1.4 Nebulizers
4.1.5 Accessories
4.2 By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue & Forecasts
4.2.1 By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue, 2019-2024
4.2.2 By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue, 2025-2030
4.2.3 By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2019-2030
4.3 By Type - Global Pulmonary Drug Delivery Devices & Systems Sales & Forecasts
4.3.1 By Type - Global Pulmonary Drug Delivery Devices & Systems Sales, 2019-2024
4.3.2 By Type - Global Pulmonary Drug Delivery Devices & Systems Sales, 2025-2030
4.3.3 By Type - Global Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2019-2030
4.4 By Type - Global Pulmonary Drug Delivery Devices & Systems Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pulmonary Drug Delivery Devices & Systems Market Size, 2023 & 2030
5.1.2 Hospitals and Clinics
5.1.3 Homecare
5.2 By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue & Forecasts
5.2.1 By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue, 2019-2024
5.2.2 By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue, 2025-2030
5.2.3 By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2019-2030
5.3 By Application - Global Pulmonary Drug Delivery Devices & Systems Sales & Forecasts
5.3.1 By Application - Global Pulmonary Drug Delivery Devices & Systems Sales, 2019-2024
5.3.2 By Application - Global Pulmonary Drug Delivery Devices & Systems Sales, 2025-2030
5.3.3 By Application - Global Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2019-2030
5.4 By Application - Global Pulmonary Drug Delivery Devices & Systems Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Pulmonary Drug Delivery Devices & Systems Market Size, 2023 & 2030
6.2 By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue & Forecasts
6.2.1 By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue, 2019-2024
6.2.2 By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue, 2025-2030
6.2.3 By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2019-2030
6.3 By Region - Global Pulmonary Drug Delivery Devices & Systems Sales & Forecasts
6.3.1 By Region - Global Pulmonary Drug Delivery Devices & Systems Sales, 2019-2024
6.3.2 By Region - Global Pulmonary Drug Delivery Devices & Systems Sales, 2025-2030
6.3.3 By Region - Global Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Pulmonary Drug Delivery Devices & Systems Revenue, 2019-2030
6.4.2 By Country - North America Pulmonary Drug Delivery Devices & Systems Sales, 2019-2030
6.4.3 US Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.4.4 Canada Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.4.5 Mexico Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Pulmonary Drug Delivery Devices & Systems Revenue, 2019-2030
6.5.2 By Country - Europe Pulmonary Drug Delivery Devices & Systems Sales, 2019-2030
6.5.3 Germany Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.5.4 France Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.5.5 U.K. Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.5.6 Italy Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.5.7 Russia Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.5.8 Nordic Countries Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.5.9 Benelux Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Pulmonary Drug Delivery Devices & Systems Revenue, 2019-2030
6.6.2 By Region - Asia Pulmonary Drug Delivery Devices & Systems Sales, 2019-2030
6.6.3 China Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.6.4 Japan Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.6.5 South Korea Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.6.6 Southeast Asia Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.6.7 India Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Pulmonary Drug Delivery Devices & Systems Revenue, 2019-2030
6.7.2 By Country - South America Pulmonary Drug Delivery Devices & Systems Sales, 2019-2030
6.7.3 Brazil Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.7.4 Argentina Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales, 2019-2030
6.8.3 Turkey Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.8.4 Israel Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.8.5 Saudi Arabia Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
6.8.6 UAE Pulmonary Drug Delivery Devices & Systems Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Hovione
7.1.1 Hovione Company Summary
7.1.2 Hovione Business Overview
7.1.3 Hovione Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.1.4 Hovione Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2019-2024)
7.1.5 Hovione Key News & Latest Developments
7.2 3M Health Care
7.2.1 3M Health Care Company Summary
7.2.2 3M Health Care Business Overview
7.2.3 3M Health Care Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.2.4 3M Health Care Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2019-2024)
7.2.5 3M Health Care Key News & Latest Developments
7.3 Bespak
7.3.1 Bespak Company Summary
7.3.2 Bespak Business Overview
7.3.3 Bespak Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.3.4 Bespak Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2019-2024)
7.3.5 Bespak Key News & Latest Developments
7.4 BeyonDevices
7.4.1 BeyonDevices Company Summary
7.4.2 BeyonDevices Business Overview
7.4.3 BeyonDevices Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.4.4 BeyonDevices Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2019-2024)
7.4.5 BeyonDevices Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.5.4 GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2019-2024)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 H&T Presspart
7.6.1 H&T Presspart Company Summary
7.6.2 H&T Presspart Business Overview
7.6.3 H&T Presspart Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.6.4 H&T Presspart Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2019-2024)
7.6.5 H&T Presspart Key News & Latest Developments
7.7 PARI Respiratory Equipment
7.7.1 PARI Respiratory Equipment Company Summary
7.7.2 PARI Respiratory Equipment Business Overview
7.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.7.4 PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2019-2024)
7.7.5 PARI Respiratory Equipment Key News & Latest Developments
7.8 Philips Respironics
7.8.1 Philips Respironics Company Summary
7.8.2 Philips Respironics Business Overview
7.8.3 Philips Respironics Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.8.4 Philips Respironics Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2019-2024)
7.8.5 Philips Respironics Key News & Latest Developments
7.9 SHL
7.9.1 SHL Company Summary
7.9.2 SHL Business Overview
7.9.3 SHL Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.9.4 SHL Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2019-2024)
7.9.5 SHL Key News & Latest Developments
8 Global Pulmonary Drug Delivery Devices & Systems Production Capacity, Analysis
8.1 Global Pulmonary Drug Delivery Devices & Systems Production Capacity, 2019-2030
8.2 Pulmonary Drug Delivery Devices & Systems Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Drug Delivery Devices & Systems Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pulmonary Drug Delivery Devices & Systems Supply Chain Analysis
10.1 Pulmonary Drug Delivery Devices & Systems Industry Value Chain
10.2 Pulmonary Drug Delivery Devices & Systems Upstream Market
10.3 Pulmonary Drug Delivery Devices & Systems Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pulmonary Drug Delivery Devices & Systems Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Pulmonary Drug Delivery Devices & Systems in Global Market
Table 2. Top Pulmonary Drug Delivery Devices & Systems Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Pulmonary Drug Delivery Devices & Systems Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Pulmonary Drug Delivery Devices & Systems Revenue Share by Companies, 2019-2024
Table 5. Global Pulmonary Drug Delivery Devices & Systems Sales by Companies, (K Units), 2019-2024
Table 6. Global Pulmonary Drug Delivery Devices & Systems Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Pulmonary Drug Delivery Devices & Systems Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Pulmonary Drug Delivery Devices & Systems Product Type
Table 9. List of Global Tier 1 Pulmonary Drug Delivery Devices & Systems Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Devices & Systems Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Pulmonary Drug Delivery Devices & Systems Sales (K Units), 2019-2024
Table 15. By Type - Global Pulmonary Drug Delivery Devices & Systems Sales (K Units), 2025-2030
Table 16. By Application ? Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Pulmonary Drug Delivery Devices & Systems Sales (K Units), 2019-2024
Table 20. By Application - Global Pulmonary Drug Delivery Devices & Systems Sales (K Units), 2025-2030
Table 21. By Region ? Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Pulmonary Drug Delivery Devices & Systems Sales (K Units), 2019-2024
Table 25. By Region - Global Pulmonary Drug Delivery Devices & Systems Sales (K Units), 2025-2030
Table 26. By Country - North America Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2019-2024
Table 29. By Country - North America Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2025-2030
Table 30. By Country - Europe Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2019-2024
Table 33. By Country - Europe Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2025-2030
Table 34. By Region - Asia Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2019-2024
Table 37. By Region - Asia Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2025-2030
Table 38. By Country - South America Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2019-2024
Table 41. By Country - South America Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2025-2030
Table 46. Hovione Company Summary
Table 47. Hovione Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 48. Hovione Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Hovione Key News & Latest Developments
Table 50. 3M Health Care Company Summary
Table 51. 3M Health Care Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 52. 3M Health Care Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. 3M Health Care Key News & Latest Developments
Table 54. Bespak Company Summary
Table 55. Bespak Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 56. Bespak Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Bespak Key News & Latest Developments
Table 58. BeyonDevices Company Summary
Table 59. BeyonDevices Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 60. BeyonDevices Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. BeyonDevices Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 64. GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. H&T Presspart Company Summary
Table 67. H&T Presspart Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 68. H&T Presspart Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. H&T Presspart Key News & Latest Developments
Table 70. PARI Respiratory Equipment Company Summary
Table 71. PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 72. PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. PARI Respiratory Equipment Key News & Latest Developments
Table 74. Philips Respironics Company Summary
Table 75. Philips Respironics Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 76. Philips Respironics Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Philips Respironics Key News & Latest Developments
Table 78. SHL Company Summary
Table 79. SHL Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 80. SHL Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. SHL Key News & Latest Developments
Table 82. Pulmonary Drug Delivery Devices & Systems Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 83. Global Pulmonary Drug Delivery Devices & Systems Capacity Market Share of Key Manufacturers, 2022-2024
Table 84. Global Pulmonary Drug Delivery Devices & Systems Production by Region, 2019-2024 (K Units)
Table 85. Global Pulmonary Drug Delivery Devices & Systems Production by Region, 2025-2030 (K Units)
Table 86. Pulmonary Drug Delivery Devices & Systems Market Opportunities & Trends in Global Market
Table 87. Pulmonary Drug Delivery Devices & Systems Market Drivers in Global Market
Table 88. Pulmonary Drug Delivery Devices & Systems Market Restraints in Global Market
Table 89. Pulmonary Drug Delivery Devices & Systems Raw Materials
Table 90. Pulmonary Drug Delivery Devices & Systems Raw Materials Suppliers in Global Market
Table 91. Typical Pulmonary Drug Delivery Devices & Systems Downstream
Table 92. Pulmonary Drug Delivery Devices & Systems Downstream Clients in Global Market
Table 93. Pulmonary Drug Delivery Devices & Systems Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pulmonary Drug Delivery Devices & Systems Segment by Type in 2023
Figure 2. Pulmonary Drug Delivery Devices & Systems Segment by Application in 2023
Figure 3. Global Pulmonary Drug Delivery Devices & Systems Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Pulmonary Drug Delivery Devices & Systems Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Pulmonary Drug Delivery Devices & Systems Revenue, 2019-2030 (US$, Mn)
Figure 7. Pulmonary Drug Delivery Devices & Systems Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pulmonary Drug Delivery Devices & Systems Revenue in 2023
Figure 9. By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2019-2030
Figure 11. By Type - Global Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2019-2030
Figure 12. By Type - Global Pulmonary Drug Delivery Devices & Systems Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2019-2030
Figure 15. By Application - Global Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2019-2030
Figure 16. By Application - Global Pulmonary Drug Delivery Devices & Systems Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2019-2030
Figure 20. By Region - Global Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2019-2030
Figure 21. By Country - North America Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2019-2030
Figure 22. By Country - North America Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2019-2030
Figure 23. US Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2019-2030
Figure 28. Germany Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 29. France Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2019-2030
Figure 37. China Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 41. India Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2019-2030
Figure 43. By Country - South America Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2019-2030
Figure 44. Brazil Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2019-2030
Figure 48. Turkey Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2019-2030
Figure 52. Global Pulmonary Drug Delivery Devices & Systems Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Pulmonary Drug Delivery Devices & Systems by Region, 2023 VS 2030
Figure 54. Pulmonary Drug Delivery Devices & Systems Industry Value Chain
Figure 55. Marketing Channels
